Self-Monitoring And Administration Devices - NAPLEX

1. A 67-year-old woman (74 kg) with type 2 diabetes is switching from insulin vial/syringe to insulin lispro U-100 prefilled pen for mealtime coverage. Current medications: insulin glargine 30 units nightly, insulin lispro 8 units with meals (pen), metformin 1000 mg twice daily. Pertinent labs: hemoglobin A1c 8.6%. Allergies: none. What is the most important counseling point for this device?
   Answer: Use a new needle for each injection and never leave the needle attached between uses to reduce leakage and contamination This question tests key counseling for insulin pens in diabetes management. The key patient-specific factor is the switch from vial/syringe to pen for mealtime insulin, with elevated A1c indicating need for optimal administration. Using a new needle for each injection and never leaving the needle attached between uses to reduce leakage and contamination is the best choice as it prevents air entry, insulin crystallization, and infection. Sharing the pen risks cross-contamination; injecting through clothing can introduce lint and bacteria; keeping the pen refrigerated and warming under hot water risks temperature instability and pain. Prime before each use and store at room temperature when in use. A decision framework is to emphasize single-use needles and proper storage to maintain insulin efficacy and patient safety.
2. A 49-year-old man (weight 104 kg) with hypertension brings a new upper-arm home blood pressure monitor to the pharmacy and asks how to get accurate readings. Current medications: amlodipine 10 mg by mouth daily, hydrochlorothiazide 25 mg by mouth daily, ibuprofen 400 mg by mouth three times daily as needed for knee pain. Pertinent values: clinic blood pressure 154/92 mmHg today. Allergies: none. Medical history: hypertension, osteoarthritis. What is the most important counseling point for this device?
   Answer: Use the correct cuff size on a bare upper arm, sit quietly for 5 minutes with back supported and arm at heart level, and take two readings 1 minute apart This question evaluates proper home blood pressure monitoring technique for accurate readings. The patient's elevated clinic reading (154/92 mmHg) necessitates accurate home monitoring to guide therapy adjustments. Proper technique includes using correct cuff size on bare skin, sitting quietly for 5 minutes with back supported and feet flat, positioning arm at heart level, and taking two readings 1 minute apart then averaging them (choice C is correct). Measuring immediately after exercise captures artificially elevated readings due to physiological response, not reflecting resting blood pressure (choice A is incorrect). Placing cuff over clothing interferes with accurate readings by creating uneven pressure distribution (choice B is incorrect). Standing measurements are used specifically to assess orthostatic changes, not routine monitoring, and single readings are less reliable than averaged multiple readings (choice D is incorrect). The clinical pearl is that standardized technique with proper positioning, rest period, and multiple readings ensures reproducible measurements for treatment decisions.
3. A 30-year-old woman (58 kg) with asthma is prescribed a budesonide dry powder inhaler (DPI) for daily control. Current medications: budesonide DPI 1 inhalation twice daily, albuterol HFA 2 puffs as needed. Pertinent values: no recent hospitalizations; using albuterol 4 times/week. Allergies: none. How should the patient use the device correctly?
   Answer: Inhale rapidly and deeply through the device after loading the dose, then hold the breath about 10 seconds This question tests proper technique for dry powder inhalers (DPIs) in asthma control. The key patient-specific factor is the new DPI prescription for daily budesonide, with moderate albuterol use suggesting need for correct inhalation to optimize therapy. Inhaling rapidly and deeply through the device after loading the dose, then holding the breath about 10 seconds is the best choice as DPIs require forceful inhalation to disperse the powder effectively into the lungs. Exhaling into the mouthpiece contaminates the dose; using a spacer is incompatible with DPIs; rinsing and storing wet promotes bacterial growth. Rinse mouth after use to prevent thrush. A clinical pearl is that DPI efficacy depends on patient-generated inspiratory flow, so assess technique and consider alternatives for those with low flow rates.
4. A 27-year-old man (68 kg) with type 1 diabetes is prescribed a glucagon emergency kit and asks how it differs from his insulin pens. Current medications: insulin lispro via pen with meals, insulin glargine 20 units nightly, glucagon emergency kit (new). Pertinent values: recent severe hypoglycemia requiring assistance. Allergies: none. Which action should the pharmacist take to ensure proper device use?
   Answer: Train the patient and a caregiver to reconstitute glucagon only when needed, inject intramuscularly or subcutaneously per product instructions, and call emergency services if severe hypoglycemia occurs This question tests the pharmacist's role in educating patients on the proper use of glucagon emergency kits for treating severe hypoglycemia in type 1 diabetes. The key patient-specific factor is the recent episode of severe hypoglycemia requiring assistance, necessitating an emergency intervention that the patient may not be able to self-administer. Choice A is the best action because it emphasizes training both the patient and a caregiver on reconstituting glucagon only at the time of need, administering it correctly via intramuscular or subcutaneous injection, and seeking immediate medical help, which aligns with safe and effective use in emergencies. Choice B is incorrect because glucagon is not for daily preventive use but reserved for acute severe hypoglycemia when oral carbohydrates cannot be given. Choice C is suboptimal as reconstituted glucagon should be used immediately and discarded, not stored at room temperature for up to 30 days due to stability issues; choice D is wrong because glucagon kits are for injection, not inhalation of powder from the vial, which is ineffective and unsafe. A key clinical pearl is that glucagon administration should always be followed by emergency medical services contact, as it provides temporary relief and underlying causes need evaluation. Pharmacists should routinely verify patient and caregiver understanding of emergency devices through teach-back methods to prevent misuse.
5. A 35-year-old woman (weight 70 kg) with chronic pain is prescribed a transdermal fentanyl patch 25 mcg/hour and asks how to use it safely. Current medications: fentanyl patch 25 mcg/hour every 72 hours, gabapentin 300 mg by mouth three times daily, acetaminophen 650 mg by mouth every 6 hours as needed. Pertinent values: respiratory rate 14/min, oxygen saturation 98% on room air. Allergies: codeine (nausea/vomiting). Medical history: chronic low back pain. How should the patient use the device correctly?
   Answer: Apply to clean, dry, hairless skin; press firmly for about 30 seconds; avoid heat sources (heating pads, hot baths) and remove the old patch before applying a new one This question addresses safe transdermal fentanyl patch application and use to prevent adverse effects. The patient is opioid-tolerant (already on the patch) but needs proper technique education for safety. Correct application involves clean, dry, hairless skin with firm pressure for 30 seconds to ensure adhesion, avoiding heat sources that increase absorption and overdose risk, and removing old patches before applying new ones to prevent dose stacking (choice C is correct). Applying to broken skin increases systemic absorption unpredictably and can cause toxicity (choice A is incorrect). Cutting fentanyl patches destroys the drug delivery system, causing immediate release of the entire dose with potentially fatal consequences (choice B is incorrect). Fentanyl patches are changed every 72 hours, not daily, as they provide sustained release over 3 days (choice D is incorrect). The critical safety principle is that fentanyl patches must never be cut, heated, or applied to damaged skin, and old patches must be removed to prevent accumulation.
6. A 65-year-old man (77 kg) with atrial fibrillation uses a home INR meter and asks how to handle test strips. Current medications: warfarin 4 mg daily, diltiazem ER 240 mg daily. Pertinent labs: INR 2.1 (goal 2.0–3.0). Allergies: none. What is the most important counseling point for this device?
   Answer: Keep strips in their original container as directed, protect from heat/moisture, and use immediately after removing a strip This question tests storage of INR test strips for home monitoring accuracy. The key patient-specific factor is the inquiry on strip handling in a stable anticoagulated patient. Keeping strips in their original container as directed, protecting from heat/moisture, and using immediately after removing a strip is the best choice as it preserves reagent integrity and prevents errors. Bathroom storage exposes to humidity; leaving open causes degradation; refrigerating and microwaving damages strips. Check expiration and use control tests. A clinical pearl is to treat INR strips like lab reagents, with strict environmental controls for reliable results.
7. A 58-year-old man (weight 92 kg) with type 2 diabetes presents for pharmacist counseling because his provider switched him from insulin vials to an insulin glargine 100 units/mL pen. Chief complaint: "I'm not sure I'm using this pen right." Current medications: insulin glargine 24 units subcutaneously nightly, metformin 1000 mg by mouth twice daily, lisinopril 20 mg by mouth daily, atorvastatin 40 mg by mouth nightly. Pertinent labs: fasting glucose 168 mg/dL, serum creatinine 1.0 mg/dL. Allergies: none. Medical history: type 2 diabetes, hypertension, hyperlipidemia. Which action should the pharmacist take to ensure proper device use?
   Answer: Have him perform a safety test (prime) with 2 units before each injection and confirm he holds the needle in the skin for about 10 seconds after pressing the dose button This question tests proper insulin pen technique and safety procedures for optimal drug delivery. The patient is transitioning from vials to pens and needs education on correct device use to ensure therapeutic efficacy. Performing a safety test (priming) with 2 units before each injection removes air bubbles and ensures proper flow, while holding the needle in place for 10 seconds after injection allows complete dose delivery and prevents insulin leakage (choice B is correct). Immediately removing the needle without holding can cause insulin to leak back out, resulting in incomplete dosing (choice A is incorrect). Reusing pen needles increases infection risk, causes needle dulling leading to painful injections, and can clog the needle with crystallized insulin (choice C is incorrect). In-use insulin pens should be stored at room temperature for up to 28-30 days, as refrigeration can cause condensation and affect dosing accuracy (choice D is incorrect). The clinical pearl is that proper pen technique includes priming before each use and maintaining needle placement for 10 seconds to ensure complete dose delivery.
8. A 60-year-old man (73 kg) with chronic pain is prescribed a buprenorphine transdermal patch 10 mcg/hour weekly. Current medications: buprenorphine patch (new), senna 8.6 mg 2 tablets nightly, naproxen 500 mg twice daily as needed. Pertinent values: no fever; intact skin. Allergies: none. Which action should the pharmacist take to ensure proper device use?
   Answer: Counsel the patient to rotate application sites and avoid applying to the same area repeatedly to reduce skin irritation and absorption variability This question tests site rotation for transdermal buprenorphine patches in chronic pain. The key patient-specific factor is the new prescription with intact skin, requiring prevention of irritation. Counseling the patient to rotate application sites and avoid applying to the same area repeatedly to reduce skin irritation and absorption variability is the best choice as it promotes skin health and consistent drug levels. Applying over heat increases absorption risk; trimming disrupts integrity; applying new before removing old overlaps doses. Wait 3-7 days before reusing a site. A clinical pearl is to map rotation sites and monitor skin to optimize transdermal therapy adherence and efficacy.
9. A 67-year-old man (weight 78 kg) with type 2 diabetes is newly prescribed a blood glucose meter and asks how often to check his glucose. Current medications: insulin aspart 6 units subcutaneously with meals, insulin glargine 18 units subcutaneously nightly, metformin 500 mg by mouth twice daily, aspirin 81 mg by mouth daily. Pertinent labs: hemoglobin A1c 9.1%. Allergies: sulfonamides (rash). Medical history: type 2 diabetes, coronary artery disease. What is the pharmacist's best recommendation for device use?
   Answer: Check at least before meals and at bedtime, and consider occasional post-meal checks to guide mealtime insulin dosing and detect hypoglycemia This question addresses blood glucose monitoring frequency for patients on basal-bolus insulin therapy. The patient's elevated A1c (9.1%) and use of both basal and mealtime insulin requires frequent monitoring to guide insulin adjustments and detect hypoglycemia. Checking before meals provides pre-prandial values to guide mealtime insulin dosing, bedtime checks ensure safe overnight glucose levels, and occasional post-meal checks assess mealtime insulin effectiveness (choice B is correct). Weekly random checks are insufficient for insulin users who need daily data for dose adjustments (choice A is incorrect). Checking only post-meal values misses pre-meal hypoglycemia and doesn't provide baseline values for mealtime insulin dosing (choice C is incorrect). Symptom-based checking alone is dangerous as hypoglycemia unawareness can develop, and hyperglycemia may be asymptomatic (choice D is incorrect). The clinical framework is that insulin users should monitor at least 4 times daily (before meals and bedtime) with additional checks as needed based on symptoms, activity changes, or dose adjustments.
10. A 63-year-old woman (78 kg) with type 2 diabetes is newly prescribed home blood glucose monitoring because of recent hypoglycemia symptoms. Current medications: glipizide immediate-release 10 mg twice daily, metformin 500 mg twice daily, hydrochlorothiazide 25 mg daily. Pertinent labs: hemoglobin A1c 7.4%, serum creatinine 0.9 mg/dL. Allergies: sulfonamide antibiotics (rash). She asks how to correctly use her glucometer and test strips. What is the most important counseling point for this device?
    Answer: Wash hands with soap and water and dry completely before testing to reduce false readings from sugar residue This question tests accurate blood glucose monitoring technique using a glucometer in patients with type 2 diabetes. The key patient-specific factor is the new prescription for home monitoring due to hypoglycemia symptoms, with a sulfonylurea allergy requiring careful education to avoid errors. Washing hands with soap and water and drying completely before testing to reduce false readings from sugar residue is the best choice as it ensures sample accuracy and prevents falsely elevated results. Using the same lancet indefinitely risks infection even with cleaning; applying blood to the strip first before inserting into the meter is incorrect for most devices; storing strips in a pill organizer exposes them to air and moisture, leading to degradation. Always check strip expiration and use control solution to verify meter function. A decision framework is to prioritize hygiene and proper sampling technique to minimize variability in glucose readings and guide safe therapy adjustments.
11. A 23-year-old woman (weight 60 kg) with asthma comes to the pharmacy for help because her albuterol metered-dose inhaler "doesn't seem to work." Current medications: albuterol HFA 90 mcg per actuation, 2 puffs every 4 to 6 hours as needed; fluticasone HFA 110 mcg, 2 puffs twice daily; cetirizine 10 mg daily. Pertinent values: peak flow 320 L/min (personal best 420 L/min). Allergies: none. Medical history: asthma, allergic rhinitis. How should the patient use the device correctly?
    Answer: Exhale fully, place the mouthpiece, start a slow deep inhalation while pressing the canister once, then hold the breath for about 10 seconds This question evaluates proper metered-dose inhaler (MDI) technique for optimal bronchodilator delivery. The patient's suboptimal peak flow (76% of personal best) despite having medication suggests poor inhaler technique is limiting drug delivery. Correct MDI technique involves exhaling fully, placing lips around the mouthpiece, beginning a slow deep inhalation while simultaneously pressing the canister once, then holding breath for 10 seconds to allow medication deposition in the lungs (choice A is correct). Fast, forceful inhalation causes medication to impact the throat rather than reach the lungs, reducing efficacy (choice B is incorrect). Pressing the canister twice during one inhalation delivers excessive medication and wastes doses without improving deposition (choice C is incorrect). Exhaling into the inhaler can introduce moisture that affects the valve mechanism and dose delivery (choice D is incorrect). The key principle is that slow, deep inhalation coordinated with actuation optimizes lung deposition, while breath-holding allows settling of medication particles in the airways.
12. A 66-year-old woman (weight 58 kg) with hypertension and dizziness is asked to monitor blood pressure at home to evaluate for orthostatic hypotension. Current medications: losartan 100 mg by mouth daily, chlorthalidone 25 mg by mouth daily, sertraline 50 mg by mouth daily. Pertinent values: clinic blood pressure 132/78 mmHg seated. Allergies: none. Medical history: hypertension, depression. Which action should the pharmacist take to ensure proper device use?
    Answer: Instruct her to measure after resting supine or seated, then again within 1 to 3 minutes of standing, documenting symptoms and readings for the prescriber This question addresses proper blood pressure monitoring technique for detecting orthostatic hypotension. The patient's dizziness on multiple antihypertensives requires systematic evaluation for positional blood pressure changes. Orthostatic assessment requires measuring blood pressure after resting supine or seated, then repeating within 1-3 minutes of standing, documenting both readings and associated symptoms to identify clinically significant drops (choice C is correct). Postprandial measurements assess different physiology (postprandial hypotension) and don't evaluate orthostatic changes (choice A is incorrect). Wrist cuffs are less accurate than upper arm devices, and positioning below heart level produces falsely elevated readings (choice B is incorrect). Excessive cuff inflation causes discomfort without improving accuracy and may trigger anxiety-related blood pressure elevation (choice D is incorrect). The diagnostic framework defines orthostatic hypotension as a drop of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing, requiring standardized positioning measurements.
13. A 70-year-old man (90 kg) on warfarin for deep vein thrombosis is interested in home INR testing. Current medications: warfarin 5 mg daily, trimethoprim-sulfamethoxazole started yesterday for urinary tract infection, vitamin D3 1000 units daily. Pertinent labs: INR last week 2.4 (goal 2.0–3.0). Allergies: penicillin (hives). Which monitoring parameter should be assessed for this device?
    Answer: More frequent INR checks during initiation of interacting medications that can raise INR and bleeding risk This question tests monitoring adjustments for home INR devices with drug interactions. The key patient-specific factor is the recent start of trimethoprim-sulfamethoxazole, which can potentiate warfarin and elevate INR. More frequent INR checks during initiation of interacting medications that can raise INR and bleeding risk is the best choice to detect changes promptly and adjust dosing. Daily A1c is irrelevant; monthly TSH does not ensure accuracy; weekly magnesium is not related to warfarin. Identify interactions and increase monitoring frequency. A clinical pearl is to use interaction checkers and protocol-driven INR testing to manage risks in polypharmacy patients.
14. A 61-year-old woman (68 kg) with hypertension is taking home readings that are consistently higher than clinic readings. Current medications: chlorthalidone 25 mg daily, metoprolol succinate 50 mg daily. Pertinent values: clinic blood pressure 126/78 mmHg; home readings 150–160/90–96 mmHg. Allergies: none. Which action should the pharmacist take to ensure proper device use?
    Answer: Have the patient bring the home monitor to the pharmacy/clinic to compare readings with a validated device and assess technique This question tests validation of home blood pressure monitors when discrepancies occur. The key patient-specific factor is consistently higher home readings than clinic, suggesting device or technique issues. Having the patient bring the home monitor to the pharmacy/clinic to compare readings with a validated device and assess technique is the best choice as it identifies errors and ensures accuracy. Placing cuff over clothing interferes; switching to wrist without assessment may not resolve; measuring standing misses orthostatic changes. Calibrate annually and review logs. A decision framework is to corroborate home readings with professional measurements to guide hypertension management accurately.
15. A 71-year-old man (84 kg) with atrial fibrillation is starting INR self-monitoring at home after multiple clinic no-shows. Current medications: warfarin 5 mg daily, amiodarone 200 mg daily, levothyroxine 75 mcg daily. Pertinent labs: INR today 2.3 (goal 2.0–3.0), hemoglobin 13.8 g/dL, platelets 210,000/mm3. Allergies: none. Which monitoring parameter should be assessed for this device?
    Answer: Regular comparison of home INR results with a laboratory INR (per protocol) to verify meter accuracy This question tests monitoring requirements for home INR self-testing devices in patients on warfarin. The key patient-specific factor is the initiation of home monitoring due to clinic no-shows, with concurrent amiodarone increasing INR variability. Regular comparison of home INR results with a laboratory INR (per protocol) to verify meter accuracy is the best choice as it ensures reliable results and safe anticoagulation management. Daily serum potassium is unnecessary as warfarin does not directly affect potassium; weekly fasting lipid panels are irrelevant to anticoagulant response; monthly urine glucose does not confirm calibration. Home INR testing can improve adherence but requires periodic lab correlation. A clinical pearl is to establish a protocol for home INR validation, especially with interacting drugs, to prevent over- or under-anticoagulation.
16. A 66-year-old woman (82 kg) with type 2 diabetes and peripheral neuropathy has difficulty obtaining adequate blood samples for glucose testing. Current medications: insulin detemir 22 units nightly, sitagliptin 100 mg daily. Pertinent labs: hemoglobin A1c 7.7%. Allergies: none. What is the pharmacist's best recommendation for device use?
    Answer: Recommend using a new lancet each time and adjusting the lancing device depth setting to obtain an adequate sample with less pain This question tests lancing technique for blood glucose sampling in patients with neuropathy. The key patient-specific factor is difficulty obtaining samples due to neuropathy, potentially leading to non-adherence. Recommending a new lancet each time and adjusting the lancing device depth setting to obtain an adequate sample with less pain is the best choice as it reduces tissue trauma and improves comfort. Squeezing aggressively can hemolyze the sample; reusing lancets increases pain and infection; alternate site testing is slower for hypoglycemia detection. Use the side of the fingertip and rotate sites. A decision framework is to optimize lancing settings and hygiene to facilitate consistent monitoring without discomfort.
17. A 76-year-old man (80 kg) on warfarin for a mechanical aortic valve is training on an INR self-testing meter. Current medications: warfarin 7.5 mg daily, aspirin 81 mg daily, omeprazole 20 mg daily. Pertinent labs: INR 3.0 (goal 2.5–3.5), hemoglobin 12.9 g/dL, platelets 190,000/mm3. Allergies: none. What is the most important counseling point for this device?
    Answer: Apply a large drop of capillary blood to completely fill the strip channel and start the test immediately per meter instructions This question tests sample application technique for home INR meters in anticoagulated patients. The key patient-specific factor is training on the device for a patient with a mechanical valve requiring precise INR control. Applying a large drop of capillary blood to completely fill the strip channel and start the test immediately per meter instructions is the best choice as it ensures sufficient sample for accurate measurement without errors. Using venous blood is not validated for most home meters; skipping handwashing risks contamination; doubling warfarin dose without guidance is dangerous. Wash hands and use fresh capillary blood. A clinical pearl is to follow manufacturer instructions precisely for sample size and timing to avoid invalid results and ensure safe warfarin management.
18. A 58-year-old woman (91 kg) with type 2 diabetes is on basal insulin and is asked to begin self-monitoring of blood glucose (SMBG) to guide dose adjustments. Current medications: insulin glargine 28 units nightly, metformin 1000 mg twice daily, semaglutide 0.5 mg weekly. Pertinent labs: hemoglobin A1c 8.4%. Allergies: none. Which monitoring parameter should be assessed for this device?
    Answer: Fasting blood glucose readings (with date/time) to evaluate basal insulin effectiveness and guide titration This question tests appropriate parameters for self-monitoring of blood glucose in basal insulin users. The key patient-specific factor is the request for SMBG to guide dose adjustments in a patient with elevated A1c on glargine. Fasting blood glucose readings (with date/time) to evaluate basal insulin effectiveness and guide titration is the best choice as it targets overnight control for safe adjustments. Random urine ketones are not routine; daily temperature is irrelevant; monthly sodium does not confirm accuracy. Log patterns and symptoms. A decision framework is to tailor SMBG frequency and timing to therapy goals, such as fasting for basal insulin titration.
19. A 62-year-old man (88 kg) with type 2 diabetes is prescribed insulin NPH in a pen for bedtime dosing. Current medications: insulin NPH 18 units subcutaneously nightly (pen), metformin 1000 mg twice daily. Pertinent labs: hemoglobin A1c 8.2%. Allergies: none. How should the patient use the device correctly?
    Answer: Roll the pen gently between the hands and invert it several times to resuspend the insulin before injecting This question tests preparation technique for cloudy insulin pens like NPH. The key patient-specific factor is the new NPH pen prescription with elevated A1c, requiring proper mixing for uniform dosing. Rolling the pen gently between the hands and inverting it several times to resuspend the insulin before injecting is the best choice as NPH is a suspension that settles and needs gentle mixing. Avoiding mixing is incorrect as it leads to inconsistent dosing; priming weekly wastes insulin and risks errors; injecting intravenously is dangerous and not indicated. Inspect for uniform cloudiness after mixing. A decision framework is to differentiate clear vs. cloudy insulins and apply appropriate preparation techniques to ensure therapeutic efficacy.
20. A 56-year-old man (92 kg) with type 2 diabetes presents to the pharmacy for training on a new insulin glargine U-100 prefilled pen due to persistently elevated fasting blood glucose. Current medications: metformin 1000 mg twice daily, insulin glargine 20 units subcutaneously nightly (new pen), lisinopril 20 mg daily, atorvastatin 40 mg nightly. Pertinent labs: fasting glucose 178 mg/dL, hemoglobin A1c 9.1%, serum creatinine 1.0 mg/dL. Allergies: none. Which action should the pharmacist take to ensure proper device use?
    Answer: Instruct the patient to prime the pen with 2 units and confirm a visible insulin drop before each injection, then dial and inject the prescribed dose This question tests proper administration technique for insulin glargine prefilled pens in patients with type 2 diabetes. The key patient-specific factor is the initiation of a new insulin pen device with elevated fasting glucose and A1c, requiring education on correct use to ensure efficacy and safety. Instructing the patient to prime the pen with 2 units and confirm a visible insulin drop before each injection, then dial and inject the prescribed dose, is the best choice because it removes air bubbles, ensures accurate dosing, and prevents underdosing. Advising storage in the freezer is incorrect as it can damage the insulin and increase injection pain; reusing the same needle for up to 1 week risks contamination and needle dulling; recommending vigorous shaking is suboptimal because insulin glargine is a clear solution that does not require mixing. Storing in-use pens at room temperature and using a new needle for each injection are essential to maintain insulin stability and reduce infection risk. A useful decision framework is to always demonstrate pen priming and injection technique during initial training and have the patient return-demonstrate to confirm understanding.

Start this quiz